Bill - Survivor of Prostate Cancer
Add to My Pictures
|Title:||Bill - Survivor of Prostate Cancer|
Bill was the first patient enrolled in a phase I trial at the National Institutes of Health Clinical Center in Bethesda, Maryland, to treat prostate cancer with a novel combination approach involving two immunotherapies: the vaccine PROSTVAC and the drug nivolumab.
Social media crops below, as attachments.
This image is part of the NCI Annual Plan and Budget Proposal FY 2022 collection.
See also www.cancer.gov/about-nci/budget/plan/.
|Type:||Color, Illustration (JPEG format)|
|Source:||National Cancer Institute (NCI)|
|Date Created:||September 1, 2020|
|Date Added:||September 1, 2020|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|